Columbus McKinnon Corporation: Fiscal 2021 Third-Quarter Form 10-Q Summary
Business context and reporting period
Columbus McKinnon designs, manufactures and markets motion-control and material-handling products, including hoists, actuators, rigging tools, crane solutions and digital power and motion-control systems. The filing covers the three and nine months ended December 31, 2020, compared with the corresponding periods ended December 31, 2019. Results were materially affected by COVID-19-related volume declines and operating restrictions. Approximately 47% of nine-month revenue was generated outside the United States.
Key financial metrics
| Metric | Three months ended December 31, 2020 | Year-over-year change | Nine months ended December 31, 2020 | Year-over-year change |
|---|---|---|---|---|
| Net sales | $166.5 million | Down 16.5% | $463.4 million | Down 25.2% |
| Gross profit | $55.3 million | Down 18.5% | $156.1 million | Down 28.0% |
| Gross margin | 33.2% | Down from 34.0% | 33.7% | Down from 35.0% |
| Income from operations | $10.4 million | Down 50.0% | $28.1 million | Down 61.6% |
| Operating margin | 6.3% | Down from 10.5% | 6.1% | Down from 11.8% |
| Net income (loss) | $6.6 million | Down 56.8% | $(0.5) million | Down from $50.4 million income |
| Diluted EPS | $0.27 | Down from $0.63 | $(0.02) | Down from $2.11 |
| Operating cash flow | Not separately provided | Not applicable | $71.9 million | Up from $70.3 million |
Quarterly revenue declines reflected approximately $37.8 million of lower volume attributable to COVID-19, partly offset by $1.9 million from price increases and $3.0 million from favorable foreign-currency translation. For the nine-month period, COVID-19-related volume reductions totaled approximately $166.2 million, partly offset by $6.7 million of price increases and $3.3 million of favorable currency translation.
- Cash and cash equivalents were $187.6 million at December 31, 2020, compared with $114.5 million at March 31, 2020. Cash, cash equivalents and restricted cash totaled $187.9 million.
- Operating cash flow benefited from collections and inventory reductions, including a $34.3 million reduction in receivables and a $20.8 million reduction in inventory.
- Capital expenditures were $5.9 million for the nine months, compared with $6.8 million in the prior-year period.
- Carrying-value debt totaled approximately $249.5 million, including $4.5 million due within 12 months. The Term Loan principal balance was $256.0 million.
- The $100 million Revolver had no borrowings outstanding at December 31, 2020, although $17.0 million of letters of credit reduced unutilized capacity. The Company had repaid a $25.0 million Revolver draw made earlier in fiscal 2021.
- Dividends declared were $0.06 per share per quarter, or $0.12 per share for the nine months.
Material changes versus the prior comparable periods
- Gross margin contracted because of lower volume, reduced productivity and facility-consolidation costs. Price increases net of material inflation, lower tariffs and favorable currency translation partially offset the decline.
- Selling expense decreased with lower variable costs and cost-containment actions, but increased as a percentage of sales to 12.1% for the nine-month period from 11.1%.
- General and administrative expense decreased for the nine months but increased in the quarter, primarily due to higher stock-based and incentive compensation. G&A represented 11.6% of nine-month sales versus 9.2% in the prior year.
- Nine-month results included a $18.9 million pension-plan settlement charge within other expense. Total other expense was $20.1 million versus $0.6 million in the prior-year period.
- The Company completed the consolidation of its Lisbon, Ohio facility and continued the consolidation of a French facility into Germany. It also sold a manufacturing facility in China, recognizing a $2.6 million gain.
- Goodwill increased to $339.0 million from $319.7 million, primarily from foreign-currency translation. Management reported no goodwill impairment indicators at December 31, 2020.
- The Company adopted the current expected credit-loss standard on April 1, 2020 without a material transition impact. The allowance for doubtful accounts increased to $6.4 million from $5.1 million at March 31, 2020.
Guidance, outlook, risks and unusual items
- Management expects fiscal 2021 capital expenditures of approximately $10 million to $12 million, excluding acquisitions and strategic alliances.
- Management estimates a fiscal 2021 effective tax rate of approximately negative 2% to negative 4%, primarily because of the pension-plan termination and related pretax loss.
- Management believes cash on hand, operating cash flow and borrowing capacity will fund operations, debt obligations and capital expenditures for at least the next 12 months, subject to successful execution of its business plan and working-capital management.
- The Company is pursuing business simplification, operational-excellence initiatives, new-product development and digital-platform investments to improve margins and return on invested capital. The filing does not provide specific revenue or earnings guidance.
- COVID-19 remains the principal near-term risk. Potential effects include reduced demand, facility or supplier interruptions, worker absenteeism, shipping and border disruptions, and customer credit deterioration.
- Recorded liabilities include approximately $7.2 million for probable and estimable asbestos-related claims, with an estimated liability range of $5.4 million to $9.7 million and expected payments of approximately $2.0 million over the next 12 months.
- Other recorded contingencies include $21.4 million of gross general and product-liability reserves, $5.2 million of product-related liability, $0.9 million of environmental reserves and $0.6 million of Magnetek asbestos-related reserves. Management states that pending proceedings are not expected to have a material effect on liquidity, although future charges could materially affect earnings.
- The Company expects approximately 90% of its $8.2 million of unsatisfied disclosed performance obligations at December 31, 2020 to be recognized over the following 12 months.
Most important facts for investors to verify
- Whether demand and production volumes recover from COVID-19-related declines and whether gross margins return toward historical levels.
- Whether operating cash flow remains strong after excluding working-capital benefits and the noncash pension settlement adjustment.
- Term Loan amortization, refinancing requirements, interest-rate exposure and remaining Revolver availability after letters of credit.
- The sustainability of the $0.06-per-share quarterly dividend while nine-month earnings remain negative.
- Progress and realized savings from facility consolidations, productivity programs and the Blueprint for Growth strategy.
- Future asbestos, product-liability, environmental and other contingent liabilities, including potential changes in insurance recoveries.
- Goodwill impairment sensitivity to lower revenue growth, reduced margins, weaker cash-flow forecasts or higher discount rates.